Cat's Claw.
May support immune function and joint health. Tries to calm down inflammation and fine-tune your immune system.
Reviewed March 2026
- Category
- Herb
- Also filed under
- Immune supportJoint health
What Cat's Claw is, and what it does.
- Does it work
- Maybe. The evidence is all over the place. Some small studies show it helps, others show nothing. It's a gamble, not a guarantee.
- How much to take
- 300-500mg of a standardized extract, once or twice a day. Look for one standardized to its active compounds, the oxindole alkaloids.
- Time to feel it
- Four to eight weeks of daily use. The joint comfort work reads out over that window, and it shows up as less morning stiffness rather than a moment you can point to.
- The first dose
- Absolutely nothing. This is an herb, not a drug. It needs weeks to build up.
- With regular use
- After 4-8 weeks, you might notice less joint stiffness or pain. Some people feel it helps them get sick less often. The effects are usually mild.
- How well tolerated
- Well tolerated, occasional stomach upset aside. It shifts immune signalling and clears via liver enzymes, so check with a doctor if you're pregnant, breastfeeding or on medication.
- How it feels
- Very subtle. You're not going to feel it 'kick in.' It's more about noticing what you *don't* feel over time—like that morning creakiness isn't as bad as it used to be.
- The overlooked benefit
- Labels talk about alkaloids, but the bark also carries quinovic acid glycosides and proanthocyanidins, and a water extraction pulls those far more readily than an alcohol one.
300 to 500mg a day is where Cat's Claw works.
Source: Piscoya et al. 2001 J Rheumatol (n=45 RCT); Sandoval et al. 2002 Free Radic Biol Med.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Research is mixed, with some studies showing benefits while others do not. More robust studies are needed.
- joint comfort and mobilityRandomised trial
- immune cell markers in bloodRandomised trial
- a healthy inflammatory responseIn vitro study
- antioxidant activityIn vitro study
Questions people ask about Cat's Claw.
- Is this like an herbal painkiller?
- No. A painkiller like ibuprofen blocks pain signals fast. Cat's Claw works slowly over weeks to potentially reduce the underlying inflammation.
- What does 'standardized extract' mean?
- It means the active compounds are guaranteed to be at a certain level. It's a mark of quality. Plain powders without it are a crapshoot.
- Can it 'boost' my immune system?
- It modulates it, but 'boost' is the wrong word. If you have an autoimmune disease, stimulating your immune system can make things worse. Talk to your doc.
- How long until I notice anything?
- Be patient. Give it at least 4-8 weeks of consistent daily use before you decide if it's working for you.
- Can I take it with my other meds?
- Big caution with blood thinners and immunosuppressants. It can interfere. Always check with your doctor or pharmacist first.
- Is it made from actual cat's claws?
- Thankfully, no. It's a woody vine from the Amazon that has thorns shaped like a cat's claw.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Both cat's claw oxindole alkaloids and curcumin dampen NF-kB signaling, a master regulator of inflammatory gene expression. Reaching the same regulatory node from different chemistry is why the two are long paired in joint-comfort formulas that support a normal inflammatory response.
Cat's claw acts mainly through NF-kB, while boswellic acids inhibit the 5-lipoxygenase leukotriene arm of the same cascade. Covering two separate branches is the established rationale for pairing them in connective-tissue and joint blends.
Devil's claw contributes harpagoside-driven modulation of inflammatory mediators, a route separate from cat's claw's alkaloid action on NF-kB. The two are traditional joint-comfort herbs stacked so their different chemistry supports normal musculoskeletal comfort together.
Glucosamine feeds the amino sugar backbone of cartilage glycosaminoglycans while cat's claw alkaloids act on NF-kB driven signalling in the same tissue. The two mechanisms do not overlap.
Chondroitin supplies sulfated glycosaminoglycan units that hold water in cartilage, and cat's claw quinovic acid glycosides act on the inflammatory signalling side.
MSM contributes sulfur for glycosaminoglycan sulfation and connective tissue crosslinks, a different lever from the alkaloid modulation of NF-kB that cat's claw provides.
Bromelain hydrolyses fibrin and kinin peptides that sustain swelling, a mechanical clearing action distinct from the transcriptional modulation cat's claw contributes.
Quercetin stabilises mast cells and inhibits the same NF-kB step that cat's claw quinovic acid glycosides act on, so the two converge on one signalling node from different directions.
EPA shifts the substrate pool feeding the eicosanoid enzymes, while cat's claw works upstream on the transcription of those enzymes. Substrate change plus enzyme expression change is a standard pairing logic.
Ascorbate is the required cofactor for the prolyl and lysyl hydroxylases that make collagen stable, so it underwrites the connective tissue side of a cat's claw formula.
Gingerols and cat's claw constituents both damp thromboxane driven platelet aggregation, so the effects on normal clotting add up when they are stacked. Worth flagging rather than hiding.
Salicin metabolites shift platelet eicosanoid output, and cat's claw pushes the same direction, so the combined effect on normal aggregation is greater than either alone.
Cat's claw inhibits CYP3A4 while St John's wort induces it, so the two pull the clearance of anything else in the formula in opposite directions and the net exposure becomes hard to predict.
Cat's claw bark carries proanthocyanidins and catechins alongside its oxindole alkaloids, the same structural class that grape seed extract is standardised to. Formulators pair them for a broader polyphenol profile in a single capsule. The additive part is chemical class, not a measured joint effect in people.
Catechin-rich green tea extract sits with cat's claw in blends aimed at everyday joint comfort and normal immune function. Both classes scavenge reactive species in laboratory assays. Read the pairing as formulation practice supported by shared chemistry rather than by a combination study.
Uncaria constituents and resveratrol each dampen NF-kB driven transcription in cultured cells, which is the usual mechanistic story behind their use for normal inflammatory balance. Cell-culture concordance is not evidence that the two add up in a person. Nothing here is a human combination result.
Lipoic acid and its reduced form recycle ascorbate and glutathione, which in turn maintain the reduced state of dietary polyphenols. A plant extract's phenolic fraction therefore sits inside a network rather than acting alone. The recycling chemistry is settled; that it changes any outcome from cat's claw is not.
Tannins and other polyphenols bind non-heme iron in the intestine and lower its absorption, a well-characterised food interaction seen with tea, coffee and tannin-rich botanicals. Cat's claw bark is a tannin-containing material, so the same chemistry applies. Separating an iron dose from a bark extract by a couple of hours is the standard way around it.
Polyphenol-rich extracts complex divalent minerals in the gut lumen, reducing the free fraction available to transporters. The effect is smaller for zinc than for non-heme iron but runs in the same direction. Spacing the doses avoids the question entirely.
Collagen peptides supply glycine and proline for connective tissue turnover while cat's claw contributes its alkaloid and polyphenol fraction. The two do different jobs in the same product rather than acting on one another. Their combined use is a formulation convention with separate rationales, not a tested pair.
Oral hyaluronic acid targets the connective tissue matrix while the botanical fraction is included for normal inflammatory balance. Nothing chemical connects them in the capsule. The pairing is product design.
Piperine raises systemic exposure to several co-administered plant compounds by slowing gut-wall metabolism and P-glycoprotein efflux. Applied to oxindole alkaloids this is an extrapolation from other substrates, not a measured result for Uncaria. The same mechanism means piperine can raise exposure to medicines a person is already taking.
Astragalus polysaccharides and Uncaria alkaloids appear together in immune-support formulas built from different herbal traditions. Each has its own preclinical literature on immune cell signalling. No combination study grounds the pairing.
Beta-glucan-bearing mushroom extracts and cat's claw are stacked in the same category of product for normal immune function. Their mechanisms differ, so any combined effect would be additive rather than synergistic. The basis is formulation convention.
Vitamin D receptor signalling shapes innate and adaptive immune cell behaviour, which is settled physiology, while cat's claw contributes its own botanical fraction to the same product category. The two act by unrelated routes. Nothing measures them together.
Tannins bind proteins non-specifically, including supplemental proteases and amylases, which can lower measurable enzyme activity when the two share a capsule or a glass of water. This is protein-polyphenol chemistry rather than a physiological interaction. Delivering them separately sidesteps it.
Talk to a doctor before taking Cat's Claw if any of these apply to you: Pregnancy, Breastfeeding, Autoimmune disorders, Blood-thinning medications. These are flags to check first, not effects Cat's Claw is known to cause.
Not medical advice. Show the label to your pharmacist.What Cat's Claw actually does.
Cat's claw bark comes in two different alkaloid chemotypes. One leans on pentacyclic oxindole alkaloids like pteropodine and isopteropodine, the other on tetracyclic ones including rhynchophylline and isorhynchophylline. A raw bark powder can be either, so the chemotype on the label tells you more than the species name.
Past the alkaloids, the bark brings quinovic acid glycosides, proanthocyanidins, catechins and plant sterols. Water extraction and alcohol extraction pull those fractions in different proportions, so two extracts of the same bark are not the same material.
The tannin and proanthocyanidin fraction binds proteins and divalent metal ions in the gut, the same non-specific chemistry behind what tannins do to non-heme iron absorption from food.
Oxindole alkaloids are moderately fat-loving and get worked over by liver cytochrome P450 enzymes. That's the mechanistic reason to take questions about your other medicines seriously with any concentrated bark extract.
Where Cat's Claw comes from.
The bark of a woody Amazon vine is stripped, dried and ground, then either steeped in hot water or soaked in an alcohol mix to concentrate its active compounds. Which solvent is used changes what ends up in the capsule. Because the plants are gathered wild and come in two natural chemical types, a lab test on the batch is the only way to know what is inside.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Uncaria tomentosa is a woody liana of Peruvian and neighbouring Amazon forest, mostly wild-collected rather than cultivated. Bark is stripped from mature vines; root harvesting kills the plant and is restricted in some sourcing regions.
Bark is shade or air dried to a stable moisture level then milled. Chemotype is set in the field by the individual plant, so lots are ideally kept separate and assayed rather than pooled blind.
Milled bark is extracted with hot water for a traditional decoction profile, or with an ethanol-water mix to capture a wider alkaloid range. Solvent choice is the single biggest determinant of what the finished extract contains.
Extract liquor is filtered clear of bark solids, concentrated under vacuum at reduced temperature to spare the alkaloids, and dried by spray or vacuum drying onto a carrier.
HPLC quantifies pentacyclic and tetracyclic oxindole alkaloids so a batch can be adjusted to a declared percentage. Identity testing separates Uncaria tomentosa from Uncaria guianensis, a related vine sold under the same common name.
Dried extract is blended with a flow agent and encapsulated, or the liquid extract is standardised and bottled as a tincture.
The forms it comes in.
The essence, in one line each.
- In adults with knee joint discomfort, freeze-dried cat's claw lowered pain during activity within the first week compared with placebo.Randomised trial. Piscoya et al., 2001 (Inflammation Research). PMID 11603848 ↗
- In adults with joint inflammation already on standard therapy, a pentacyclic cat's claw extract reduced the number of tender joints by about 53 percent versus 24 percent on placebo over 24 weeks.Randomised trial. Mur et al., 2002 (Journal of Rheumatology). PMID 11950006 ↗
- In healthy men, two months of a water-soluble cat's claw extract better maintained antibody titers after a pneumococcal vaccine and raised the lymphocyte-to-neutrophil ratio versus untreated controls.Randomised trial. Lamm et al., 2001 (Phytomedicine). PMID 11515716 ↗
- In healthy adults, eight weeks of a water cat's claw extract increased DNA repair after a hydrogen-peroxide oxidative challenge compared with no supplement.Randomised trial. Sheng et al., 2001 (Phytomedicine). PMID 11515717 ↗
- Across trials in adults with joint pain and stiffness, nutraceutical ingredients including cat's claw were associated with lower reported pain and function scores, with the evidence for any single ingredient thin.Meta-analysis. Aghamohammadi et al., 2020 (Scientific reports). PMID 33262447 ↗
- In active adults, a multi-nutrient supplement containing cat's claw shifted markers of inflammation and some physical performance measures, so the result belongs to the blend rather than to cat's claw alone.Randomised trial. Dunn-Lewis et al., 2011 (Nutrition journal). PMID 21899733 ↗
- The review catalogues Uncaria tomentosa constituents, chiefly oxindole alkaloids, quinovic acid glycosides and polyphenols, and reports that the described activities rest largely on preclinical work.Narrative review. Marques et al., 2025 (International Journal of Molecular Sciences). PMID 40725012 ↗
- Quinovic acid, a constituent found in Uncaria species, altered Ras/MAPK signalling and interferon-related responses in a cultured natural killer cell line; this is a cell-line signalling result, not a human outcome.In vitro study. Hsieh et al., 2025 (Journal of Cellular and Molecular Medicine). PMID 41294043 ↗
- Cat's claw appears in this review only as one of the named agents considered for treatment-related joint and muscle discomfort; the review does not report a supported conclusion for it.Systematic review. Roberts et al., 2022 (Cochrane Database of Systematic Reviews). PMID 35005781 ↗
These are the studies our verdict leans on, chosen from the 37 we read for Cat's Claw. The full linked list is below.
The studies, linked.
1 source behind our Cat's Claw verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialPercepta for Cognitive Optimization: A 6-Month Randomized Controlled Trial With Neurocognitive, Wearable, and Participant-Reported Outcomes in Adults With Mild Cognitive ImpairmentClinicalTrials.gov ↗NA · 154 participants · Not yet recruiting
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 356 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Cat's Claw is, not how risky it is. A report is not proof Cat's Claw caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.
